IL1B and rheumatoid arthritis: In view of the application of antibodies for the blockade of TNF-alpha, IL-1β and IL-6 receptor as treatments for RA, other cytokines such as IL-27 may therefore offer alternative targets for therapeutic intervention or may be useful as predictive biomarkers of established RA [57-59].